A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3-Reference-Cited by-同舟云学术

A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3

Published:2017-03-23 Issue:8 Volume:83 Page:1734-1744
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Berger Rolf M. F.¹,Gehin Martine²,Beghetti Maurice³,Ivy Dunbar⁴,Kusic-Pajic Andjela²,Cornelisse Peter²,Grill Simon²,Bonnet Damien⁵,

Affiliation:

1. Centre for Congenital Heart Diseases, Department of Paediatric Cardiology, Beatrix Children's Hospital; University Medical Centre, University of Groningen; Groningen, The Netherlands

2. Actelion Pharmaceuticals Ltd; Allschwil Switzerland

3. Children's Hospital, Paediatric Cardiology Unit; University of Geneva, Geneva, and Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatriques; Geneva and Lausanne Switzerland

4. Children's Hospital Colorado, Department of Pediatric Cardiology; Denver CO USA

5. M3C-Hospital Necker Enfants Malades, Department of Paediatric Cardiology, Université Paris Descartes; Paris France

Funder

Actelion Pharmaceuticals

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13267/fullpdf

Reference26 articles.

1. The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands;Southan;Nucleic Acids Res,2016